Skip to main content
Signal8
Chee Conley profile photo

Conley Chee

CIK: 0001883804

Transaction Breakdown

Open Market Buys (P)2 (40.0%)

High conviction signal

Open Market Sales (S)1 (20.0%)

Position reduction

Option Exercises (M)1 (20.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Syros Pharmaceuticals, Inc. logo
SYRS

Syros Pharmaceuticals, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Nov 18, 2024
    Sale(S)
    Direct
    134.8K shares at avg. $0.20$27K
  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Oct 31, 2024
    Exercise(M)
    Direct
    17K shares-
  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Oct 31, 2024
    Tax Payment(F)
    Direct
    8.7K shares at avg. $2.09$18K
  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Sep 11, 2024
    Purchase(P)
    Direct
    50K shares at avg. $1.71$85K
  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Sep 10, 2024
    Purchase(P)
    Direct
    50K shares at avg. $1.51$75K

1-5 of 5

Conley Chee files insider reports with the SEC as President & CEO of Syros Pharmaceuticals, Inc. (SYRS). Signal8 holds 5 reported Form 4/5 transactions by Conley Chee since Sep 2024. The most recent reported transaction is a sale (Form 4 code S) in SYRS, dated Nov 18, 2024.

About Chee Conley

Chee Conley (SEC CIK 0001883804) files insider reports with the SEC as President & CEO of Syros Pharmaceuticals, Inc. (SYRS).

Signal8 holds 3 ownership filings by Chee Conley, all Form 4s, filed between Sep 12, 2024 and Nov 20, 2024. Those filings report 5 transactions, from Sep 10, 2024 to Nov 18, 2024. Signal8's Form 4 history starts in Sep 2024.

The business address on Chee Conley's filings is in CAMBRIDGE, MA.

Recent filings by Chee Conley

  • Nov 18, 2024: Open-market sale of SYRS shares (Form 4, code S).
  • Oct 31, 2024: Option exercise of SYRS shares (Form 4, code M).
  • Oct 31, 2024: Tax withholding of SYRS shares (Form 4, code F).
  • Sep 11, 2024: Open-market purchase of SYRS shares (Form 4, code P).
  • Sep 10, 2024: Open-market purchase of SYRS shares (Form 4, code P).

Other insiders filing for Syros Pharmaceuticals, Inc. (SYRS)

How to read Form 4 transaction codes